MAIA Biotechnology, Inc. (MAIA)
1.15
+0.02
(+1.77%)
USD |
NYAM |
Oct 23, 16:00
1.145
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Net Income (Quarterly) : -7.944M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.944M |
| March 31, 2026 | -6.370M |
| December 31, 2025 | -3.629M |
| September 30, 2025 | -8.903M |
| June 30, 2025 | -5.347M |
| March 31, 2025 | -4.517M |
| December 31, 2024 | -3.572M |
| September 30, 2024 | -2.736M |
| June 30, 2024 | -8.879M |
| March 31, 2024 | -8.068M |
| December 31, 2023 | -6.257M |
| September 30, 2023 | -4.876M |
| Date | Value |
|---|---|
| June 30, 2023 | -4.524M |
| March 31, 2023 | -4.117M |
| December 31, 2022 | -4.146M |
| September 30, 2022 | -4.904M |
| June 30, 2022 | -3.306M |
| March 31, 2022 | -3.414M |
| December 31, 2021 | -2.893M |
| September 30, 2021 | -5.204M |
| June 30, 2021 | -3.460M |
| March 31, 2021 | -1.022M |
| September 30, 2020 | -0.8251M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.944M |
| EPS Diluted (Quarterly) | -0.1307 |
| Enterprise Value | 42.34M |
| Earnings Yield | -55.11% |
| Normalized Earnings Yield | -56.47 |